• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » InfraReDx rings up $10 million more in convertible debt sale

InfraReDx rings up $10 million more in convertible debt sale

January 14, 2010 By MassDevice staff

InfraReDx Inc. raised an additional $10 million through the sale of convertible promissory notes, according to a filing with the Securities and Exchange Commission, taking the Burlington, Mass.-based company’s total fundraising effort to nearly $100 million after more than a decade of operation.

A spokesman for the company told MassDevice that the firm wouldn’t be making any comment on the new round until CEO James Muller returned from presenting at the JP Morgan Healthcare Investors Conference in San Francisco this week.

InfraReDx, which launched in 1999, uses both ultrasound waves and near-infrared light to provide images of the coronary plaque believed to cause most heart attacks, aiming to help surgeons determine not only the shape of the plaque but its composition. The device is designed to help doctors assess the likelihood of further cardiovascular problems stemming from the plaque lining patients’ blood vessels.

Despite its success in raising money, InfraReDx has had difficulty winning reimbursement for its equipment from the Centers for Medicare and Medicaid Services, according to the New York Times. The system costs more than $157,000: $155,000 for a control unit and $2,400 for a single-use catheter. Company officials told the Times they had no expectations of profits before 2011 at the earliest and were burning up to $30,000 a day.

The firm raised $17 million in 2008, but has had to cut costs over the past year, including initiating layoffs during the spring of 2009. Sanderling Ventures of San Diego, which led the last round of financing, did not respond to calls seeking comment on this round.

In May, 2009,InfraReDx announced that a new generation of its product, an optical/acoustic imaging catheter, was used for the first time in patients undergoing angiography in the Netherlands.

Filed Under: Business/Financial News, News Well Tagged With: InfraReDx Inc.

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy